Gossamer Bio Statistics
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.72-0.51 (-4.54%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Gossamer Bio by the numbers
Gossamer Bio has a market capitalization of $65.6 million based on 6.12M shares outstanding. With trailing EPS of $-42.41, Gossamer Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.0% above its 50-day average and 59.7% below its 200-day average.
Average daily trading volume is 243.40K shares, or about $2.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GOSS valuation vs. peer median
| Metric | GOSS | Peer median | Difference |
|---|---|---|---|
| Market cap | $65.57M | $66.70M | -2% |
| Avg. volume | 243.40K | 230.15K | +6% |
Peer median across 8 companies: PMVP, PLYX, FBIO, MNOV, CING, MAIA, VTVT, COYA.
Valuation
- Market cap
- $65.57M
- Price / sales (latest FY)
- 1.35
- EPS (TTM)
- $-42.41
- Shares outstanding
- 6.12M
Price and trading
- Previous close
- 11.23
- Open
- 11.02
- Day range
- 10.65 – 11.60
- 52-week range
- 8.29 – 309.60
- 52-week change
- -95.62%
- Beta
- —
- Volume
- 191.36K
- Average volume
- 243.40K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 65.57M
- Forward Pe
- -0.88
- Eps
- -42.41
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 309.60
- Week52 Low
- 8.29
- Avg Volume
- 243.40K
- Shares Outstanding
- 6.12M
- Ma50
- 10.40
- Ma200
- 26.58
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -96.54%
- Pct From52w Low
- 29.31%